The effects of paraquat on regional brain neurotransmitter activity, hippocampal BDNF and behavioural function in female mice

Neuroscience Letters

Volumn 502, Issue 3, 2011, Pages 186-191

  Litteljohn, Darcy ^a   Nelson, Eric ^a   Bethune, Cheri ^a   Hayley, Shawn ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

BDNF; Behaviour; Female; Monoamine; Paraquat; Parkinson's disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROTRANSMITTER; NORADRENALIN; PARAQUAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIORAL RESEARCH; BRAIN REGION; FEMALE; HIPPOCAMPUS; LOCOMOTION; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OPEN FIELD TEST; OUTCOME ASSESSMENT; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; HERBICIDES; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; NEUROTRANSMITTER AGENTS; PARAQUAT; PARKINSONIAN DISORDERS; SYNAPTIC TRANSMISSION;

EID: 80052347079     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.07.041     Document Type: Article

References (24)

1. Anisman H., Merali Z., Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog. Neurobiol. 2008, 85:1-74.
2. Bokov A.F., Ko D., Richardson A. The effect of gonadectomy and estradiol on sensitivity to oxidative stress. Endocr. Res. 2009, 34:43-58.
3. Bourque M., Dluzen D.E., Di Paolo T. Neuroprotective actions of sex steroids in Parkinson's disease. Front. Neuroendocrinol. 2009, 30:142-157.
4. Brooks A.I., Chadwick C.A., Gelbard H.A., Cory-Slechta D.A., Federoff H.J. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res. 1999, 823:1-10.
5. Chen P., Chen Z., Li A., Lou X.C., Wu X.K., Zhao C.J., Wang S.L., Liang L.P. Catalytic metalloporphyrin protects against paraquat neurotoxicity in vivo. Biomed. Environ. Sci. 2008, 21:233-238.
6. Chen Q., Niu Y., Zhang R., Guo H., Gao Y., Li Y., Liu R. The toxic influence of paraquat on hippocampus of mice: involvement of oxidative stress. Neurotoxicology 2010, 31:310-316.
7. Costello S., Cockburn M., Bronstein J., Zhang X., Ritz B. Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am. J. Epidemiol. 2009, 169:919-926.
8. Dluzen D.E., McDermott J.L., Anderson L.I. Tamoxifen eliminates estrogen's neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system. Neurotox. Res. 2001, 3:291-300.
9. Dluzen D., Horstink M. Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies. Endocrine 2003, 21:67-75.
10. Gélinas S., Bureau G., Valastro B., Massicotte G., Cicchetti F., Chiasson K., Gagne B., Blanchet J., Martinoli M.G. Alpha and beta estradiol protect neuronal but not native PC12 cells from paraquat-induced oxidative stress. Neurotox. Res. 2004, 6:141-148.
11. Huang C.F., Wang Y.R., Yen C.H., Chou S.H., Lau Y.T. Paraquat-induced lipid peroxidation: effects of ovariectomy and estrogen receptor antagonist. Chin. J. Physiol. 2006, 49:141-146.
12. Latourelle J.C., Dybdahl M., Destefano A.L., Myers R.H., Lash T.L. Risk of Parkinson's disease after tamoxifen treatment. BMC Neurol. 2010, 10:23.
13. Li X., Yin J., Cheng C.M., Sun J.L., Li Z., Wu Y.L. Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice. Chin. Med. J. (Engl.) 2005, 118:1357-1361.
14. Liou H.H., Tsai M.C., Chen C.J., Jeng J.S., Chang Y.C., Chen S.Y., Chen R.C. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997, 48:1583-1588.
15. Litteljohn D., Mangano E., Shukla N., Hayley S. Interferon-gamma deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat. Neuroscience 2009, 164:1894-1906.
16. Litteljohn D., Mangano E., Clarke M., Bobyn J., Moloney K., Hayley S. Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease. Parkinson's Dis. 2011, 2011:18. 10.4061/2011/713517.
17. Mangano E.N., Peters S., Litteljohn D., So R., Bethune C., Bobyn J., Clarke M., Hayley S. Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease. Neurobiol. Dis. 2011, 43:99-112.
18. Mangano E.N., Litteljohn D., So R., Nelson E., Peters S., Bethune C., Bobyn J., Hayley S. Interferon-γ plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways. Neurobiol. Aging 2011, (April 9). (Epub ahead of print).
19. Miller D.B., Ali S.F., O'Callaghan J.P., Laws S.C. The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann. N. Y. Acad. Sci. 1998, 844:153-165.
20. Pavon J.M., Whitson H.E., Okun M.S. Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research. Maturitas 2010, 65:352-358.
21. Rocca W.A., Bower J.H., Maraganore D.M., Ahlskog J.E., Grossardt B.R., de Andrade M., Melton L.J. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 2008, 70:200-209.
22. Shulman L.M. Gender differences in Parkinson's disease. Gend. Med. 2007, 4:8-18.
23. Sohrabji F., Miranda R.C., Toran-Allerand C.D. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:11110-11114.
24. Wooten G.F., Currie L.J., Bovbjerg V.E., Lee J.K., Patrie J. Are men at greater risk for Parkinson's disease than women?. J. Neurol. Neurosurg. Psychiatry 2004, 75:637-639.